Cenduit Reaches New Milestone of More Than 400 Employees

RESEARCH TRIANGLE PARK, NC, UNITED STATES - May 29, 2015 - Cenduit, a joint venture between Quintiles and Thermo Fisher Scientific, today announced it has achieved a new milestone of more than 400 employees. Building on its strategic growth initiative for 2015, Cenduit has hired 43 new professionals this year and is actively looking to fill a number of new positions in the U.S. and abroad.

Cenduit will hire positions in its new Business Intelligence Division, located primarily in the Research Triangle Park region of North Carolina. The division was created in direct response to customer demand, driven by the exponential growth in data acquisition and computing power, along with the emergence of interactive visual analytics. Building on Cenduit’s patient and drug management systems expertise, the Business Intelligence team will focus on the incorporation of analytics to forecast future data points - helping clinical trial managers stay better informed and enable optimization of trial efficiency and patient compliance.

“We are happy to be in a position of growth and reaching the 400-employee milestone is a testament to our team of talented IRT professionals,” said Jogin Desai, CEO, Cenduit. “With an eight-year track record of steady business expansion, we look forward to building on our position as the largest Interactive Response Technology (IRT) specialist in the world and making new strides in providing superior solutions to support the needs of patients and sites.” 

In addition to new hires for its new Business Intelligence Division, Cenduit will also be hiring for multiple positions across different business segments located in Research Triangle Park;  Allentown, Pennsylvania; Bangalore, India and Basel, Switzerland.

To learn more about these available positions, visit Cenduit Careers.

About Cenduit

Cenduit, a joint venture between Quintiles and Thermo Fisher Scientific, is the largest IRT specialist in the world with the expertise to empower sponsors for success by implementing a completely personalized system that puts them in control of their clinical trials. With the needs of investigator sites and patients top of mind, Cenduit offers clinical supply chain intelligence and clinical operations know-how through its IRT-driven services: patient randomization, patient reminders, drug supply management, and eClinical integration. Cenduit has offices in the US, UK, Switzerland, India, and Japan, and global clinical trial experience in more than 100 countries, interacting with more than 600,000 patients at more than 32,000 sites. For additional information, visit Cenduit online at www.cenduit.com; on Twitter @CenduitLLC or on LinkedIn at www.LinkedIn.com/Company/Cenduit.

###